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Abstract
Purpose: Dmp1 (dentin matrix protein1) null mice (Dmp12/2) display hypophosphatemic rickets with a sharp increase in
fibroblast growth factor 23 (FGF23). Disruption of Klotho (the obligatory co-receptor of FGF23) results in
hyperphosphatemia with ectopic calcifications formed in blood vessels and kidneys. To determine the role of DMP1 in
both a hyperphosphatemic environment and within the ectopic calcifications, we created Dmp1/Klotho compound deficient
(Dmp12/2kl/kl) mice.
Procedures: A combination of TUNEL, immunohistochemistry, TRAP, von Kossa, micro CT, bone histomorphometry, serum
biochemistry and Scanning Electron Microscopy techniques were used to analyze the changes in blood vessels, kidney and
bone for wild type control, Dmp12/2, Klotho deficient (kl/kl) and Dmp12/2kl/kl animals.
Findings: Interestingly, Dmp12/2kl/kl mice show a dramatic improvement of rickets and an identical serum biochemical
phenotype to kl/kl mice (extremely high FGF23, hyperphosphatemia and reduced parathyroid hormone (PTH) levels).
Unexpectedly, Dmp12/2kl/kl mice presented elevated levels of apoptosis in osteocytes, endothelial and vascular smooth
muscle cells in small and large blood vessels, and within the kidney as well as dramatic increase in ectopic calcification in all
these tissues, as compared to kl/kl.
Conclusion: These findings suggest that DMP1 has an anti-apoptotic role in hyperphosphatemia. Discovering this novel
protective role of DMP1 may have clinical relevance in protecting the cells from apoptosis in high-phosphate environments
as observed in chronic kidney disease (CKD).
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Introduction
Physiologically, phosphate (Pi) is critical not only for the health
of mineralized tissues such as bone and teeth, but is also essential
for a variety of biological processes, including energy metabolism,
cell signaling, nucleic acid synthesis, and membrane function [1].
Pathologically, low blood Pi levels lead to hypophosphatemic
rickets [2,3]; whereas high blood Pi levels, even in the upper-to-
normal range, have been linked to increased mortality within
populations of both general and chronic kidney disease (CKD)
[4]. To maintain Pi homeostasis, parathyroid hormone (PTH)
and 1, 25-dihydroxy vitamin D (1,25 (OH)2D3) play an
important role via their regulation of phosphate absorption in
the intestines and reabsorption in the kidney [5]. Recent findings
suggest that FGF23 is a more specific and potent phosphaturic
hormone [6,7,8]. FGF23, mainly expressed in bone, targets the
kidney to remove phosphate with little effect on calcium
homeostasis [9,10]. Fgf23 null mice display increased renal
phosphate reabsorption and increased serum 1,25 (OH)2D3
levels, which results in hyperphosphatemia, hypercalcemia, and
vascular calcification [10].
DMP1, an extracellular matrix phosphoprotein highly ex-
pressed in hard tissues such as the skeleton and teeth, belongs to
small integrin ligand N-linked glycoprotein family [11,12].
Deletion of Dmp1 in mice or mutations in DMP1 in humans
causes hypophosphatemic rickets with an elevated circulating level
of FGF23, which is responsible for the impaired renal tubular
reabsorption of phosphate [13,14]. The abnormalities observed in
Dmp1 null mice include decreased endochondral ossification,
defects in bone lengthening and remodeling, increase in the width
of the bone (flaring), and an increased metaphysis area
[15,16,17,18]. A number of these characteristics are related to
the direct role of DMP1 as a regulator of osteocyte maturation
[19], whereas other characteristics are secondary to impaired Pi
homeostasis [8].
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Klotho, a transmembrane protein predominantly expressed in
the kidney, was initially identified as an anti-aging gene prior to mm
the discovery of FGF23 during which a loss-of-function study in
mice showed a striking aging phenotype encompassing hair loss,
infertility and emphysema [20]. Interestingly, Fgf23 null mice
unexpectedly exhibited almost an identical aging phenotype as
that of Klotho-deficient (kl/kl) mice [10]. On the other hand, kl/kl
mice display high serum levels of phosphate, calcium, and vitamin
D, which is very similar to that of the Fgf23 null phenotype [21].
Furthermore, mechanistic studies demonstrated that FGF23
requires not only the FGF receptors (FGFRs), but also Klotho,
as FGF23 is able to bind to FGFRs with high affinity only in the
presence of Klotho. This suggests that Klotho is an obligatory co-
receptor of FGF23 [22]. One of the major complications in kl/kl
mice is the high frequency of formation of ectopic calcifications in
the blood vessels and kidney. This is assumed to be the
consequence of either high serum phosphate levels [23], cell
death that occurs in CKD patients [24], or the matrix vesicles
released from the dead vascular smooth muscle cells [25].
As DMP1, a key regulator of FGF23 [13,14], is also expressed in
blood vessels and kidney tissues [26,27], we explored the potential
(beneficial or harmful) role of DMP1 in soft tissue calcification
within Dmp12/2kl/kl compound mice lacking both Klotho and
Dmp1. This model displayed high phosphate retention and
increased FGF23 levels which resemble chronic kidney disease
(CKD). We also attempted to test whether elevation of blood Pi
levels due to Klotho deficiency would rescue the rickets phenotype
in Dmp12/2 mice. Our data support a novel concept that DMP1
plays an important role in blocking ectopic calcification in Klotho
deficient mice via its anti-apoptotic function within a high
phosphate environment.
Materials and Methods
Ethical Approval
All mice were maintained under guidelines established by
Baylor College of Dentistry Institution of Animal Care and Use
Committee (IACUC). IACUC has specifically given ethical
approved for all the procedures in this study.
Animals
Klotho-deficient mice (kl/kl) and Dmp1 lacZ knock-in null mice
(Dmp12/2) were described previously [20,28]. The kl/kl mouse
was originally described as a severe hypomorph strain because
extremely low levels of Klotho mRNA were detectable only by
RT-PCR [20]. However, Klotho protein was undetectable in any
tissues by immunoblot, immunoprecipitation, and immunohi-
sotchemical analyses (data not shown). In addition, kl/kl mice were
shown to exhibit the same phenotypes as Klotho2/2 mice [29].
Thus, the kl/kl mouse is virtually equivalent to a null strain. All the
mice were fed with tap water and autoclaved Purina rodent chow
(5010, Rastlon Purina) containing calcium, 0.67% phosphorus and
4.4 international units of vitamin D/g.
Generation of Dmp1/Klotho Compound Deficient Mice
Both Dmp1 and Klotho genes in mice are located on chromosome
5 (qE5 and qG3 respectively). The generation of Dmp1/Klotho
compound deficient mice (Dmp12/2kl/kl) was based on the chance
of cross-over between homologous chromosomes. First, we crossed
Dmp12/2 and Klotho-deficient heterozygous mice (kl/+). Their
offspring will include male and female heterozygous mice for both
Dmp1 and Klotho (Dmp1+/2 kl/+) which were set for litter-mating.
In the first three generations, no cross-over occurred. After the
third generation, Dmp1 null Klotho hetero animals (Dmp12/2kl/+)
were born and used for mating with a one-in-four chance for
producing compound homozygous mice (Dmp12/2kl/kl). At the
same time compound hetero mice (Dmp1+/2 kl/+) were also
continued mating to generate wild type (WT), Dmp12/2 and kl/kl
animals; A few Dmp12/2kl/kl mice were also born through this set
of mating.
Genotyping
DNA was extracted from the toe of each mouse by standard
protocol and subjected to PCR for genotyping. Dmp1+/2 and
Dmp12/2 were genotyped by PCR as reported previously [28].
For Dmp1, the PCR program consisted of 4 minutes initial
denaturation at 94uC, amplification cycle including denaturation
at 94uC for 1 minute, annealing at 55uC for 2 minutes, and
extension for 3 minutes at 72uC, and final extension was
performed at 72uC for 10 minutes. The expected product size
for the targeted Dmp1 allele was 280 bp and the wild type allele
was 410 bp. The Klotho genotyping protocol and the primers used
have been previously mentioned [30]. Briefly for Klotho genotyp-
ing, Takara LA Taq and buffer were used and the protocol for
PCR included 2 minutes initial denaturation at 94uC, amplifica-
tion cycle consisting denaturation at 94uC for 30 seconds,
annealing at 56uC for 30 seconds, and extension for 1.5 minute
at 72uC, which was followed by final extension at 72uC for
10 minutes. The expected product size for WT Klotho was 458 bp
and for mutant Klotho was 920 bp.
Serum Biochemistry
Blood was collected directly from the heart by using needle for
WT, kl/kl, Dmp12/2 and Dmp12/2 kl/kl mice before they were
sacrificed at 6 weeks of age. Serum was isolated and stored at -
80uC. Serum phosphorous, calcium, PTH, vitamin D, and FGF23
levels were measured as described previously [8]. Briefly, the
serum phosphorous level was measured by the phosphomolibdate-
ascorbic acid method. Serum calcium Controlent analysis was
performed using the colorimetric calcium kit (Stanbio laboratory).
For measuring serum FGF23, we used full length FGF23 ELISA
kit (Kainos Laboratories). PTH serum levels were measured using
Mouse PTH 1-84 ELISA Kit (Immutopics, Inc. San Clemente,
CA), and the level of 1, 25 hydroxyvitamin D (1, 25 (OH)2D3) was
measured in serum of all four groups of mice using 1,25 Dihydroxy
Vitamin D EIA kit (Immunodiagnostic System, Fountain Hills,
AZ).
Histology, Immunohistochemistry and TUNEL Staining
The right tibias of 6 week old mice were collected, fixed in 4%
paraformaldehyde in phosphate buffered saline (pH 7.4) for
48 hours, decalcified by microwave EDTA for 16 hours, dehy-
drated through graded alcohol and then embedded in paraffin.
Sections were cut 4.5 mm thick and were mounted on slides and
dried. Slides were used for Safranin O and TRAP staining as
previously described [11]. Growth plate width was measured for at
least 3 mice in each group for Safranin O staining. TRAP positive
cells were counted in the area including 300 mm down the growth
plate for 3 mice in each group, and the number of the cells was
divided by the area for each slide. For immunohistochemistry,
mouse anti-alpha rhFGF-23 antibody (Cell Essential) was used on
tibias of four study groups including WT, Dmp12/2, kl/kl, and
Dmp12/2kl/kl animals. To analyze apoptosis in tissues the
TUNEL kit (Roche Diagnostics, IN, USA) was used and the
number of apoptotic osteocytes in a 1006500 mm2 area was
counted in each group. Kidney and aorta samples were fixed and
embedded in paraffin without decalcification, and stained for Von
Kossa (calcification) and TUNEL (for apoptosis). For undecalcified
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femurs, samples were embedded in methyl methycrylate, and cut
by a Leica 2165 rotary microtome (Ernst Leitz Wetzlar) at a 6 mm
thickness. Three samples in each group were stained by Goldner’s
masson trichrome staining [8].
Microcomputed Tomography (mCT), Radiography, and
Sacnning Electron Microscopy (SEM)
After the fixation, femurs were dissected and radiographs was
taken using Faxitron radiographic inspection unit (Model 8050,
Field Emission Corporation, Inc), with digital capture image
capability.
Femur cortical and trabecular compartments were quantified
using an X-ray microCT imaging system (mCT 35, Scanco
Medical, Basserdorf, Switzerland). Serial tomographic imaging at
an energy level of 55 kV and intensity of 145 mA for the femurs
was performed. To analyze the trabecular region, we used 500
cross sectional slides in a constant area under the growth plate in
all samples. The area was determined as 100 slides lower than the
lowest part of growth plate. In addition, cortical thickness data was
Figure 1. Macroscopic phenotype of Dmp1/Klotho compound deficient mice (Dmp12/2kl/kl). (A) Gross appearance of Wild Type (WT),
Dmp1 null (Dmp12/2), Klotho deficient (kl/kl), and compound deficient (Dmp12/2kl/kl) mice at 6 weeks of age. (B) Body weights of 6 weeks old mice,
showing a decrease in Dmp12/2 (13%), kl/kl (57%) and Dmp12/2kl/kl (36%) mice compared to the age matched WT (P = 0.02; P,0.001, and P,0.001
respectively; n = 10 in each group). Note that the Dmp12/2kl/kl body weight was , 30% higher than that of the single kl/kl mice (P = 0.03). (C)
Survival for WT, Dmp12/2, kl/kl, and Dmp12/2kl/kl mice (n = 10 in each group). Both kl/kl and Dmp12/2kl/kl mice showed similar low survival rate
compared to WT and Dmp12/2 groups. About 40% of Dmp12/2kl/kl animals survived 3 weeks more than single kl/kl. Neither of the kl/kl nor Dmp12/
2kl/kl groups survived more than 15 weeks. None of WT and Dmp12/2 animals died in 30 weeks of observation period. These mice were of similar
genetic backgrounds but not necessarily littermates. *P,0.05 compared to WT; 1 P,0.05 compared to kl/kl.
doi:10.1371/journal.pone.0042329.g001
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obtained at the midshaft of the bone. For this purpose, cortical
bones from 100 cross sectional slices above the midshaft of the
femur were analyzed. The threshold used for this analysis was 335
for trabecular bone and 283 for cortical bone. Micro CT imaging
system was also used to evaluate and compare the calcification
level in kidneys of all four groups of mice. Bone volume/total
volume of each group was calculated and used for comparison.
To image the osteocyte lacunocanalicular system, SEM of resin
casted bone samples was performed. Bone tissues were fixed in
70% ethanol and embedded in MMA (Buehler, Lake Bluff, IL,
USA). The surface of the MMA-embedded bone was polished,
followed by acid etching with 37% phosphoric acid for 2 to
10 seconds, 5% sodium hypochlorite for 5 minutes, and coating
with gold and palladium. Samples were examined by an FEI/
Philips XL30 field emission environmental SEM (Phillips,
Hillsboro, OR, USA). For Backscattered Electron Microscopy
imaging we used the method described previously [17].
Bone Histomorphometry
Using bioquant software, the analysis of osteoid and mineralized
bone was performed on the cortical bone area of tibias of the four
groups of mice. The identification of mineralized and osteoid area
was based on their color in Goldner’s masson trichrome staining;
orange to red represents osteoid, and blue represents well
mineralized bone. The ratio of mineralized bone or osteoid on
total volume of the bone is reported in percent.
Fluorochrome Labeling of the Mineralization Front
Compound fluorescence labeling was performed to visualize the
bone mineralization rate in all four groups of WT, Dmp12/2, kl/kl
and Dmp12/2kl/kl as described previously [31]. Briefly the first
intraperitoneal injection was performed using calcein green
(5 mg/kg), followed by injection of an alizarin red label (5 mg/
kg i.p.; Sigma- Aldrich) 5 days later. Mice were sacrificed after
48 hours. The tibias were collected and fixed in 70% ethanol for
48 hours. Without decalcification the samples were dehydrated
through a graded series of ethanol (70% to 100%) and embedded
in methyl methacrylate. Then 15-mm sections were cut using a
Leitz 1600 saw microtome (Ernst Leitz Wetzlar GmbH, Wetzlar,
Germany). The unstained sections were viewed under epifluor-
escent illumination using a Nikon (Melville, NY, USA) E800
microscope.
Primary Cell Culture for Osteoblasts and Colorimetric
TUNEL Assay
Calvarial cells, enriched for cells with an osteoblast phenotype,
were isolated from 3 day old Dmp12/2 pups and age-matched
control pups using procedures described previously [28]. Briefly,
the first-passage cells were plated at density of 26104 cells/well in
96-well tissue culture dishes (Costar, Corning, NY, USA). Cells
Figure 2. The changes of bone volume/mineral content
(reflected by BV/TV) and femur length in Dmp12/2, Klotho
deficient (kl/kl) and the compound deficient (Dmp12/2 kl/kl) at
age of 6-weeks. (A) Representative X-ray (upper panel) and
backscattered SEM (lower panel) images of the hind limbs obtained
from wild type (WT), Dmp12/2, kl/kl and Dmp12/2 kl/kl mice. (B)
Representative mCT images of the above four group femurs at the
longitudinal front view (upper panel), and the midshaft cross section
view (lower pane). (C) Quantitative mCT data shows moderate changes
of femur length in Dmp12/2, kl/kl and Dmp12/2kl/kl mice compared to
the age-matched WT control (P,0.001, P,0.001, and P = 0.03
respectively; n = 10). Note that the femur length difference between
the Dmp12/2kl/kl mice and kl/kl (P,0.001) or Dmp12/2 (*P,0.05) are
significant. (D) The Quantitative mCT data show a sharp reduction of BV/
TV in the Dmp12/2 cortical bone (P,0.01), and there is no significant
change between WT and kl/kl or the Dmp12/2kl/kl (left panel). In
contrast, there is a significant increase in metaphysis BV/TV in Dmp12/2
(.80%, P,0.01) or in the kl/kl (.50%, P,0.01) or in the Dmp12/2kl/kl
mice (.60%, P,0.01) separately (right panel).
doi:10.1371/journal.pone.0042329.g002
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were grown to confluence in a-MEM supplemented with 10%
FBS. The medium then was changed to a-MEM supplemented
with 10% FBS only (normal media), or supplemented with 1 or
5 mM of phosphate added to normal media. After 24 hours of
incubation with the new media, cells were fixed in 4% PFA for
7 minutes and washed in PBS. To evaluate and compare apoptosis
between the different groups, HT Titer TACS colorimetric assay
kit (Trevigen, Gaithersburg, MD, USA) was used. Briefly cells
were treated with Cytonin for 30 minutes and after wash with
dH2O. After incubation with hydrogen peroxidase, TdT labeling
buffer was used for 5 minutes. Then samples were incubated with
stop buffer followed by adding Strep HRP solution was to samples
for 10 minutes. Samples were washed and incubated by Saphire
solution for 30 minutes in dark. Reaction stopped by 0.2 N HCl
and absorbance measurement was done at 450 nm. For the cell
proliferation assay, Cell Counting Kit-8 was used. Cell prolifer-
ation was assessed according to the instruction of the CCK-8 kit
(BI Yuntian Co, China). In brief, after incubation with normal
media for 24 hours, 10 mL WST-8 was added to each well, and
the plates were incubated for an additional 4 hrs at 37uC to
convert WST-8 into formazan. The absorbance of each plate was
measured at 450 nm (absorbance) with spectrophotometer. The
absorbance presents as OD450 nm represents a direct correlation
with the cell number in the well.
Figure 3. The effect of deletion of Klotho on histological features of the Dmp12/2 growth plate and metaphysis area. (A) Growth plates
and metaphysis of proximal tibias obtained from WT, Dmp12/2, kl/kl, and Dmp12/kl/kl (Safranin O staining x200). Note that there is an expansion of
metaphysis in the kl/kl, which is similar to that of the Dmp12/2 and Dmp12/2kl/kl mice. (B) growth plate width comparison between all four groups
of the mice shows increase of phosphate in both kl/kl and Dmp12/2kl/kl mice resulted in decreased growth plate width compared to WT (P = 0.009
and 0.024 respectively). Values reported in mean 6 SE from more than 3 mice in each group at 6 weeks of age. *P,0.05 compared to WT; 1 P,0.05
compared to Dmp12/2 group.
doi:10.1371/journal.pone.0042329.g003
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RT-PCR and Real Time PCR (qPCR)
For real time PCR (qPCR), the total RNA was extracted from
mouse tissues in both the kidney and humerus at 6 weeks of age.
To evaluate the net expression of FGF23 mRNA in osteocytes, the
osteoblastic layer on the surface and bone marrow were both
removed. Total RNA was isolated from the kidneys, and cortical
bone using TRI-reagent (Molecular Research Center, Cincinnati,
OH, USA) as described previously [11]. First-strand cDNA was
synthesized from the kidney RNAs using iScript cDNA Synthesis
kit (SA Biosciences, Frederick, USA). The 20 mL reverse
transcriptase reaction was based on 1 mg total RNA. The iCycler
iQ Real-Time PCR Detection System and iQ SYBR Green
Supermix (Agilent Technologies, USA) were used for real-time
quantitative PCR analysis. The expression was normalized by
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the same
sample and expressed as 100% of the control (WT). The forward
Figure 4. Ablation of Klotho rescued bone formation rate and osteomalacia phenotype in the compound deficient (Dmp12/2 kl/kl)
mice. (A) Confocal microscope images of flurochrome labeling of 6 weeks old mice tibias (red: alizarin red, green: calcein). Note that in the
Dmp12/kl/kl mice the bone formation labeling pattern is similar to that of the control and the kl/kl mice. (B) Goldner’s stain showed the massive
osteoid (red) areas commonly seen in the Dmp12/2 long bone, which was restored to normal in the Dmp12/2kl/kl mice. (C, D), Quantitative bone
histomorphometric analyses showed that the above changes of the osteoid area (C) and the mineralized area (blue in color) (D) were statistically
significant. *P,0.05; **P,0.01 compared to the WT; (n = 3 in each group).
doi:10.1371/journal.pone.0042329.g004
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primer sequence used for qPCR for the Dmp1 gene is 5
9AGTGAGTCATCAGAAGAAAGTCAAGC 39 and the reverse
primer is 59 CTATACTGGCCTCTGTCGTAGCC 39.
Western Blot
Total protein from the kidney was extracted by 5ml extraction
reagent (4M guanidine hydrochloride and 0.5 M EDTA) followed
Figure 5. The compound deficiency of Klotho and Dmp1 increases osteoclast number to the normal level (6 weeks old mice). (A)
TRAP-stained metaphysis of the proximal tibias obtained from WT, Dmp12/2, kl/kl and compound deficient (Dmp12/2kl/kl) mice. (B) Quantitative
analyses of TRAP positive cells per mm2 in each group. Values reported in mean6 SE from 3 mice in each group. Osteoclast number in Dmp12/2 and
kl/kl bones were significantly lower than WT (P,0.001 for both), while in the Dmp12/2kl/kl group it were restored to the same level as of WT. *P,0.05
compared to WT; 1 P,0.05 compared to Dmp12/2; ¥ P,0.05 compared to kl/kl.
doi:10.1371/journal.pone.0042329.g005
Protective DMP1 in High Phosphate Homeostasis
PLoS ONE | www.plosone.org 7 August 2012 | Volume 7 | Issue 8 | e42329
by centrifugation (20 min, 10000 rpm, 4uC). The supernatant
protein solution was then collected and went through a buffer
change procedure (to the final concentration at 0.1M NaCl/6M
Urea). The urea-protein buffer was loaded to the Q-sephorose
column in Fast Protein Liquid Chromatography (FPLC) for acidic
proteins (such as DMP1) separation with a gradient buffer elution
range at 0.1–0.8M NaCl/6 M urea. Next, Stains-All staining was
used to profile DMP1 and other acidic proteins in all the
chromatographic fractions. For Western immunoblotting, anti-
DMP1-C-857 and osteocalcin [32] was used at 1:1000 for one
hour. Blots were washed three times in PBS containing 0.3%
Tween 20, followed by incubation in the alkaline phosphate-
conjugated anti-rabbit IgG (Sigma Aldrich; Louis, MO) at a
dilution of 1:5000. Finally, the blots were incubated with the
chemiluminescent substrate CDP-Star (Ambion; Austin, TX) for
5 min and exposed to X-ray films [33].
Statistics
The differences were evaluated among groups by one way
ANOVA, with Benferoni correction and P,0.05 was considered
as statistical significance. The values are reported in mean 6 SE.
For statistical analysis we used SPSS software.
Results
Compound Dmp1 Klotho Deficient Mice Display an
Improvement in Growth Retardation
From a gross overview, there was no apparent difference
between Dmp12/2 and wild type (WT) control mice except for a
mild reduction in body weight (Fig. 1A–B). The body weight of
both the kl/kl and compound deficient mice was significantly lower
than that of the WT mice. The body weight of the compound
deficient mice was slightly improved compared to that of the kl/kl
mice, likely due to an increase in skeleton length and ectopic
ossification after a switch from hypophosphatemia to hyperphos-
phatemia. Consistent with previously reported literature
[20,21,34] kl/kl mice showed a distinct premature aging pheno-
type, including emphysema, generalized atrophy of the skin,
spleen, intestine, skeletal muscle, reproductive organs, and
infertility, which was also evident in Dmp12/2kl/kl animals (data
not shown). However, none of these phenotypes were observed in
Dmp12/2 mice.
Compared to the age matched WT mice, both kl/kl and
Dmp12/2kl/kl mice survived for a shorter length of time than WT
mice, and neither kl/kl nor Dmp12/2kl/kl mice survived longer
Figure 6. Changes of serum biochemistry profiles in Dmp12/2, kl/kl and the Dmp12/2 kl/kl mice. (A) Serum Phosphate levels were
significantly lower in Dmp12/2 mice (P,0.001), while there was a significant increase in kl/kl and the Dmp12/2kl/kl groups (P,0.001) compared to
WT (n = 7 in each group). (B) Serum calcium levels were statistically unchanged in Dmp12/2 and kl/kl mice. However, the calcium level was
significantly higher in the Dmp12/2kl/kl mice than that of the WT (P = 0.04). (C) Serum PTH level was over 10 fold increased in Dmp12/2 but
significantly lower in both kl/kl and the Dmp12/2 kl/kl mice compared to WT (P = 0.025, and P= 0.002 respectively). (D) Serum 1,25(OH)2D3 levels were
overall higher in all these deficient mice, although only kl/kl mice showed significant difference compared to the WT (P = 0.043). (E) Serum FGF23
levels were high in all three deficient mice with kl/kl the highest compared to the WT control. *P,0.05 compared to WT, 1 P,0.05 compared to
Dmp12/2, ¥ P,0.05 compared to kl/kl mice.
doi:10.1371/journal.pone.0042329.g006
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than 15 weeks (Fig. 1C). In contrast, there was no difference
between the Dmp12/2 and WT mice regarding their survival rate
(Fig. 1C). Interestingly, about 80% of kl/kl mice died before the
age of 9 weeks, while 60% of Dmp12/2kl/kl mice survived longer
than 12 weeks, suggesting that ablation of Dmp1 in kl/kl
background improves the life span of kl/kl mice (Fig. 1C).
Ablation of Klotho Partially Rescued Rickets Features in
Dmp12/2 Mice
The classical characteristics of the rickets phenotype in Dmp12/2
mice, including the expanded growth plate, enlarged diaphysis, and
shorter long bone length have been previously reported [17], and it
was proposed that both hypophosphatemia and the direct local role
of DMP1 are responsible for these pathological changes [2,8,19].
Here we show a dramatic improvement of the osteomalacia and
rickets phenotypes in Dmp12/2kl/kl compared to Dmp12/2mice at
6-weeks of age through the use of radiography, backscattered SEM
(Fig. 2A) and mCT imaging (Fig. 2B). Quantitative data displayed a
moderate but significant improvement in the Dmp12/2kl/kl femur
length when compared to the Dmp12/2 femur (Fig. 2C). Note that
there was over a 25% reduction of bone volume/total volume (BV/
TV) (reflecting relative changes in bone volume density) in the
Dmp12/2 cortical bone compared to the age-matched control
(P,0.01, Fig. 2D, left panel), which was restored in the Dmp12/2kl/
kl cortical bone with no significant difference compared to the WT
control (P = 0.125). Interestingly, there was a significant increase in
the BV/TV in Dmp12/2 metaphysis (.80%) and kl/kl metaphysis
which was also present inDmp12/2kl/kl. Taken together, our x-ray,
backscattered SEM, and mCT data showed that there is a significant
improvement of BV/TV in the compound long bone. This
improvement, plus the restoration of the growth plate and bone
length inDmp12/2kl/klmice compared toDmp12/2mice was likely
due to a switch from hypophosphatemia to hyperphosphatemia,
although the probable local role of Klotho ablation in this
phenotypic rescue should not be ignored.
Removing Klotho in Dmp12/2 Background Improves
Histological Abnormalities of the Growth Plate and
Cortical Bone Mineralization
To determine the effect of Klotho deletion on Dmp12/2
phenotypes at the histological level, we first confirmed the
previous reports [15] showing irregular and disorganized chon-
drocytes and expanded hypertrophic zone in the Dmp1 growth
plate, which was rescued in Dmp12/2kl/kl mice (Fig. 3A–C),
although the quantitative data displayed a small but significant
reduction of the growth plate width in kl/kl and Dmp12/2kl/kl
mice compared to the age matched control (Fig. 3B). All these
changes (WT, 24464.8 mm; Dmp12/2, 447631.6 mm; kl/kl,
154.5614.12 mm; and Dmp12/2kl/kl, 16669.6 mm) are statisti-
cally significant. It appears that the identical growth plate
phenotype in kl/kl and Dmp12/2kl/kl is a consequence of a
change in Pi homeostasis (see Discussion for details).
Next, we examined changes of mineralization in Dmp12/2kl/kl
mice using a fluorescent double label assay (alizarin red complex-
one and calcein). The diffuse fluorochrome labeling pattern
commonly observed in Dmp12/2 mice was restored to a pattern
similar to that in both control and single kl/kl mice with discrete
lines of calcein and alizarin red labeling, suggesting a normal
bone-formation rate (Fig. 4A). Bone mineralization quality, as
reflected by an increase in osteoid area (Goldner stain), is very
poor in the Dmp12/2 long bone, but appears fully rescued in the
compound deficient mice as compared to WT and kl/kl mice using
both qualitative and quantitative analyses (Fig. 4B–D).
To address the effect of the Klotho deletion on the abnormal
bone remodeling commonly observed in Dmp12/2 mice [19], we
examined the number of TRAP (a marker for osteoclastic cells)
positive cells, which was sharply reduced in both Dmp12/2 and kl/
kl but not in the Dmp12/2kl/kl metaphysis at 6 weeks of age
(Fig. 5A). The above changes were statistically significant
(Fig. 5B, P,0.05; n = 3). The reduced osteoclast number in kl/
kl mice may explain in part why there was an increase in the
trabecular bone within the metaphysis area (Fig. 2A). Interest-
ingly, in Dmp12/2kl/kl, the osteoclast number was restored to
levels seen in the WT control (Fig. 5B). This restoration likely
contributed to the improved bone remodeling process in
compound deficient mice (Fig. 2).
Dmp12/2kl/kl Mice Displayed a Similar Serum
Biochemical Profile as that in a Single kl/kl Mouse
One of the key differences betweenDmp12/2 and kl/klmice is the
Pi level: the former shows hypophosphatemia due to an abnormal
increase of FGF23 that leads to Pi waste [8] and the latter is
associated with hyperphosphatemia, which is due to a failure of
FGF23 to remove extra Pi in the absence of Klotho, the key co-
receptor [20,35]. In addition to its phosphaturic activity, FGF23
suppresses the synthesis of 1, 25 dihydroxyvitamin D3
(1,25(OH)2D3). As low 1,25(OH)2D3 stimulates PTH production
and secretion, there is secondary hyperparathyroidism in Dmp12/2
mice [8] and PTH suppression in kl/klmice [35]. To clarify whether
bone morphological changes as described above are linked to serum
biochemical profile changes in these animals, serum levels of Pi, Ca,
FGF23, PTH, and 1,25(OH)2D3 were analyzed. Overall, both kl/kl
and Dmp12/2kl/kl animals shared a similar biochemical profile,
including ,30% increase in Pi, a moderate increase in Ca and
1,25(OH)2D3, and a suppression of PTH (Fig. 6A–D). Surprisingly,
the FGF23 level in Dmp12/2kl/kl mice was between the levels of
Dmp12/2 and kl/kl mice (Fig. 6E).
Dmp12/2kl/kl Mice Display Massive Ectopic Calcifications
and Apoptosis in the Aorta and Kidney
Klotho deficient mice (kl/kl) displayed increased serum levels of
1,25(OH)2D3 and widespread vascular and kidney calcifications
[36], which was completely reversed when the 25-Hydroxyvitamin
D3 1-alpha-hydroxylase (1a-hydroxylase, the enzyme which
Figure 7. Sharply increased ectopic calcification and apoptosis in the compound deficient (Dmp12/2 kl/kl) mice. (A) Representative X-
ray images of kidney and aorta in four groups show moderate ectopic calcifications in the kl/kl kidney and aorta, and massive ectopic calcification in
the Dmp12/2kl/kl kidney and aorta. (B) von-Kossa stain (left panel) and TUNEL assay (right panel) of the Dmp12/2kl/kl kidney showing a close
correlation between the calcified- and apoptotic cells. (C) A similar linkage between the ectopic calcification (von-Kossa stain; right panel) and the
apoptosis (TUNEL assay; right panel) was observed in the adjacent Dmp12/2kl/kl aorta. (D) The quantitative mineral content is sharply increased in
both the kl/kl and the Dmp12/2kl/kl kidney by mCT analysis with significantly higher in the Dmp12/2kl/kl kidney than that of the single kl/kl kidney
(P = 0.041). Values are means 6 SEM of 3–5 kidneys. Note that there was no calcification in the WT and the Dmp12/2 mice. (E) Representative DMP1
Western blots with WT at left panel and kl/kl at right panel shows higher density of DMP1 in kl/kl. Osteocalcin (OCN) is the matrix protein which does
not show difference between these two groups. (F) Quantitative kidney RT-PCR data showing over two fold-increases of Dmp1 mRANA in kl/kl
compared to the WT control. n = 3, *P,0.05.
doi:10.1371/journal.pone.0042329.g007
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catalyzes the hydroxylation of calcidiol to calcitriol, the bioactive
form of Vitamin D) was deleted [37]. It is also known that Pi is
essential for the apoptosis of terminally differentiated hypertrophic
chondrocytes in vivo [17,38], and that high Pi led to apoptosis in
osteoblasts [39] and in endothelial cells in vitro [40]. Furthermore,
DMP1 was expressed in the blood vessels [26] and the kidneys
[41]. To address whether DMP1 plays any role in the ectopic
calcification in kl/kl mice we first confirmed DMP1-lacZ
expression in the blood vessels and the kidney (Fig. S3–S4).
Next, we examined the kidney and the aorta and observed
exacerbated calcification by X-ray images (Fig. 7A) and by von
Kossa staining (Fig. 7B–C). The TUNEL assay showed a close
correlation between calcification and apoptosis in endothelial and
vascular smooth muscle cells, and a very small number of renal
tubules. Calcification and apoptosis in the kidney was observed
primarily within small blood vessels in both kl/kl and Dmp12/2kl/
kl mice (Fig. 7B–C). Quantitative data further confirmed that the
ectopic ossification in the Dmp12/2kl/kl kidney was statistically
significant (Fig. 7D). In contrast, neither WT nor Dmp12/2 mice
displayed ectopic calcification or increased levels of apoptosis (data
not shown). The increase in apoptotic cells in the Dmp12/2kl/kl
mice was confirmed by a Caspase 3 assay and H&E stained empty
lacunae (Fig. S2). Furthermore, Western Blot and quantitative
real time PCR (qPCR) data confirmed that within the kl/kl kidneys
the expression of DMP1 is higher than that in the WT kidneys,
which might be due to a compensatory mechanism protecting
against the toxic effect of high Pi. The above data clearly suggests
that DMP1 plays an important anti-apoptotic role in hyperphos-
phatemia, and that deletion of Dmp1 in kl/kl mice leads to
exacerbated calcification in the kidney and the aorta.
Deletion of Klotho in the Dmp12/2 Mice Greatly
Accelerated Osteocyte Dendrite Loss
DMP1 is highly expressed in osteocytes, but Klotho is not.
Using an acid-etched resin casting SEM technique, which revealed
detail morphologies of WT osteocytes (Fig. 8A), we confirmed
Dmp12/2 osteocyte abnormalities (including the presence of a
rough membrane surface with a sharp reduction of dendrites,
Fig. 8B) [8], and showed minor changes in kl/kl osteocyte
dendrite number (Fig. 8C). Unexpectedly, there was a much more
dramatic change in osteocyte morphology with few osteocyte
dendrites remaining (Fig. 8D) in Dmp12/2kl/kl mice compared to
the age matched control. The above data indicates that DMP1 is
not only necessary for osteocyte maturation and differentiation as
previously reported [8], but also plays a protective role in a high
phosphate environment in maintaining a normal osteocyte
morphology.
Unique FGF23 Expression Patterns in Dmp12/2, kl/kl and
Dmp12/2kl/kl Bone Cells
Although FGF23 was sharply increased in Dmp12/2 and kl/kl
mice, the causes are different in each mouse model: an increase of
FGF23 in the former model is primary to Pi retention while the
increase in the latter model is secondary to Pi retention. As the
primary FGF23 source is osteoblast cells, we first compared
FGF23 expression patterns in the four animal groups using an
immunohistochemistry (IHC) assay. FGF23 was mainly expressed
in WT osteoblast cells, which was consistent with data previously
reported [8,19]. There was a sharp increase in FGF23 expression
in the Dmp12/2 osteocytes (with no FGF23 expression changes in
the osteoblasts), a moderate increase in kl/kl osteocytes with a
massive increase in kl/kl osteoblasts (which can be assumed as the
main source for higher FGF23 serum level in kl/kl compared to all
other groups), and a dramatic increase in Dmp12/2kl/kl osteocytes
(Fig. 9A). To better define the changes in FGF23 expression in
osteocytes, fresh long bones (femurs) were collected, bone marrow
cells were flushed out and the periosteum was removed. Real-time
RT-PCR (qPCR) data confirmed a significant increase in Fgf23
mRNA in kl/kl, Dmp12/2 and Dmp12/2kl/kl osteocytes with
Dmp12/2kl/kl having the highest (,5-fold) increase (Fig. 9B). To
address whether there was a potential linkage between the changes
of FGF23 levels and apoptosis in these bones, we further examined
apoptotic bone cells using the TUNEL assay. There were few
detectable TUNEL positive bone cells in WT and Dmp12/2
femurs. In contrast, there was a moderate amount of apoptotic
bone cells in kl/kl femurs and many apoptotic osteocytes in the
Dmp12/2kl/kl femurs (Fig. 9C). Performing quantitative analysis
on osteocyte cell death showed that the apoptotic cell number in
kl/kl mice was significantly higher than that of WT mice (Fig. 9D;
P = 0.027), and the number of Dmp12/2 apoptotic cells was lower
although with no significance (P= 0.056). The Dmp12/2kl/kl
apoptotic cells were the highest amongst all four groups (P,0.001,
n = 3). Taken together, the above data showed 1) different FGF23
expression patterns in these three groups with a high level in kl/kl
osteoblasts; 2) an anti-apoptotic role of DMP1 in a high phosphate
environment; and 3) a possible correlation between a sharp up-
regulation of FGF23 expression and an increase of apoptotic cell
number in Dmp12/2kl/kl osteocytes.
Discussion
Although DMP1 is expressed in both hard and soft tissues, the
phenotype in human DMP1 mutations or Dmp1 deficient mice was
mainly identified in the skeleton and the teeth, likely caused by
hypophosphatemia, and increased FGF23 levels [3,8,27,28].On the
other hand, defects or mutations in Fgf23 or Klotho resulted in
hyperphosphatemia, premature aging, and the formation of ectopic
calcifications [20,42]. To investigate the potential role of DMP1 in
the Klotho deficient mice we generated and characterized compound
deficient (Dmp12/2kl/kl) mice using a combination of in vitro and
in vivo approaches. Our studies revealed a novel anti-apoptotic
function of DMP1 in a high phosphate environment (caused by
Klotho ablation) (also see Figure S2), followed by severe ectopic
calcifications within the Dmp12/2kl/kl kidney and aorta. There is
also a unique distribution of FGF23 within kl/kl, Dmp12/2 and
Dmp12/2kl/kl bones. These findings may stimulate future studies of
the roles of DMP1 in prevention of vascular calcification in
hyperphosphatemic environments such as those within chronic
kidney disease (CKD).
Almost all patients with cardiovascular disease have some degree
of ectopic calcification in their blood vessels and kidneys [43],
although the most-extensive vascular calcification occurs in CKD
patients that is closely linked to hyperphosphatemia [44]. Recent
Figure 8. Acid-etched resin casting SEM (upper panels) and backscattered SEM (lower panels) images of osteocytes in four animal
groups. (A). Representative SEM images showed well organized WT osteocytes which were generally straight and run perpendicular to the long axis
of the osteocyte with numerous dendrites; (B). The Dmp12/2 osteocyte appeared much larger in size, and the distribution of the osteocytes were less
organized with a sharp reduction in the dendrite number; (C). The kl/kl osteocytes were less straight and more randomly oriented with moderate
reduction in osteocyte dendrites; (D). The Dmp12/2kl/kl osteocytes, much larger in size, showed absence of dendrites with poor organization in their
cell distributions.
doi:10.1371/journal.pone.0042329.g008
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Figure 9. The effect of Ablation of Dmp1 in Klotho deficient background increases apoptosis and FGF23 expression in osteocytes. (A)
FGF23 immunostaining shows in Dmp12/2 and in Dmp12/2kl/kl animals the expression of FGF23 is detectable in both osteocytes (OC) and
osteoblasts (OB), while in kl/kl mice it is mainly expressed in osteoblasts with much higher density compared to WT. (B) Quantitative real time PCR on
bone after removal of osteoblast layer in Dmp12/2 shows increased FGF23 expression compared to WT (P = 0.016), but this expression was
significantly higher in Dmp12/2kl/kl osteocyte (P,0.001). (C) TUNEL staining on four groups of mice shows dramatic increase in double deficient mice
(Dmp12/2kl/kl) even compared to single kl/kl in osteocytes. (D) Counting apoptotic cells in 500 mm2 of slides shows Dmp12/2 has significantly lower
rate of apoptosis compared to WT (P = 0.027), and this rate is higher in both kl/kl and the Dmp12/2kl/kl mice (P = 0.05 and P,0.001 respectively).
Ablation of Dmp1 in Dmp12/2kl/kl mice increased apoptosis rate in osteocytes even compared to single kl/kl (P,0.001). (OC, osteocyte; OB,
osteoblast).
doi:10.1371/journal.pone.0042329.g009
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studies suggest that two key factors are responsible for vascular
calcification in hyperphosphatemia: 1) up regulation of osteogenic
factors such as Osterix, Cbfa1, and several bone-associated proteins
(Osteopontin, Bone Sialoprotein, Alkaline Phosphatase, and Type I
Collagen) [44,45] and 2) phosphate-induced apoptosis [24,25].
Furthermore, the recombinant Klotho protein itself is able to
attenuate cellular apoptosis and senescence through mitogen-
activated kinase and extracellular signal-regulated kinase pathways
[46]. Here, for the first time, we showed that DMP1 plays an anti-
apoptotic function in a high phosphate environment, whichmakes it
a critical factor for the attenuation of calcification in the aorta and
the kidneys in a hyperphosphatemic environment such as within
CKD disease (Fig. 7). This anti-apoptotic role was also observed in
bone (Fig. 9C–D), as well as in osteoblast cell culture (Fig. S1)
when the phosphate level increased. It appears that this protection is
important for maintaining osteocyte morphology in a high
phosphate environment, as there was only a moderate loss of
osteocyte dendrites in the kl/kl mice in contrast to dramatic loss of
osteocyte dendrites in Dmp12/2kl/kl mice (Fig. 8).
It is well documented that FGF23 is mainly produced and
secreted from bone cells. However, it was debatable whether
FGF23 is secreted from osteocytes or osteoblasts [6,8,19,47,48].
Here, our immunohistochemical data showed that FGF23 was
mainly expressed in the osteoblast cell layer with a low level of
expression in the osteocytes in both WT and kl/kl mice, whereas
FGF23 was mainly expressed in the osteocyte in both Dmp12/2
and Dmp12/2kl/kl mice (Fig. 9A). The qPCR data was in
agreement with the above immunohistochemical data (Fig. 9B).
Although we do not know the mechanistic details for such a
difference in the sites of FGF23 expression among these animal
models, the high level of FGF23 in the Dmp12/2 osteocytes was
likely the consequence of the defect in the osteocyte maturation
process [8,19,48]. In these studies, we showed that DMP1 is highly
expressed in osteocytes with an extremely low level in the WT
osteoblasts, and that Dmp12/2 mice displayed pathological
changes in the osteocyte, including morphological changes in
lacunocanalicular system, defects in matrix surrounding the
osteocytes, up-regulation of many genes expressed in normal
osteoblasts (such as type I collagen or BSP) or ectopically produced
(such as FGF23 and osteocalcin). It appears that there was a close
correlation between the high expression levels of FGF23 and the
accelerated levels of apoptosis within the Dmp12/2kl/kl osteocytes
(Fig. 9C–D and Fig. S2). Our future study seeks to understand
why and how apoptotic osteocytes release more FGF23 in this
animal model.
Dmp12/2 mice, like hyp mice (a well-studied hypophosphatemic
rickets animal model) [49], display abnormally high FGF23, low
serum Pi, rickets and osteomalacia, which is a consequence of the
defects in the osteocytes [2,8,19]. The administration of a high
phosphate diet [8] or performing injections of FGF23 neutralizing
antibody [19] can fully rescue the rickets phenotype but is only
partially restored in osteomalacia. However, Dmp12/2kl/kl mice
display no sign of rickets or osteomalacia (Fig. 4), as these mice
were never exposed to hypophosphatemia. Regarding the
similarity of FGF23 and 1,25(OH)2D3 in both Dmp1
2/2 and
Dmp12/2kl/kl mice, this study does not support the direct roles of
these two factors in Dmp12/2 bones (Fig. 3). Furthermore, the
bone volume/total volume and osteoclast number/bone remod-
eling were greatly improved in the Dmp12/2kl/kl mice, supporting
the early beneficial role of Pi administration in restoring the local
bone phenotype (Figs. 2 and 5).
Interestingly, the serum Ca level in Dmp12/2 mice is relatively
‘‘normal’’ compared to the age matched WT control (Fig. 4B),
although the Dmp12/2 osteoclast cell number is reduced more
than 50% (Fig. 5). This ‘‘normal Ca level’’ in Dmp12/2 mice is
likely caused by an increase of renal Ca reabsorption, as the PTH
level was up-regulated almost 10-fold (Fig. 4C).
Both Fgf232/2 and Klotho deficient mice share many similarities
such as hyperphosphatemia, high 1,25(OH)2D3 levels, ectopic
ossification in the soft tissues, and several lines of compelling evidence
suggest that FGF23’s function in the regulation of systemic phosphate
and vitamin D homeostasis is klotho-dependent [3,21,50]. However,
there is a notable difference between these two types of mice: an
increase in bone volume in the Klotho deficient tibial metaphysis
(Fig. 2) [51], but a reduction of bone volume in Fgf232/2 tibial
metaphysis [11]. Liu et al. showed evidence of increased Wnt
signaling in Klotho deficient mice, suggest a unique antagonistic role
against Wnt by Klotho [52]. Furthermore, the apoptotic phenom-
enon has not been reported in Fgf232/2 mice.
In conclusion, this study presented an increase of apoptosis in
the Dmp1/klotho compound deficient mice, which is closely linked
to substantial increase of ectopic ossification in the aorta and in the
kidney. Discovering this novel anti-apoptotic role of DMP1 in a
hyperphosphatemic environment may have important clinical
relevance in uncovering a method to protect cells from apoptosis
in high phosphate environments such as that which occurs in
CKD patients. Our studies also showed improvement of the
rickets/osteomalacia phenotype, and dramatically enhanced bone
modeling in the compound deficient mice, suggesting that the low
phosphate level plays a key pathological role in Dmp12/2 mice.
Supporting Information
Figure S1 Cell proliferation and apoptosis in osteo-
blasts. As a result of protective role of DMP1 in hyperphospha-
temia, increase in phosphate level increases the apoptosis level
significantly in Dmp12/2 cells while it has no significant effect on
WT cells in vitro; Primary calvarial cells were isolated from control
(WT) and Dmp12/2 mice at age of 3-day after birth. Cells were
grown in a-MEM supplemented with 10% FBS only (normal
media), or added 1 or 5 mM of phosphate to the normal media.
After 24 hours of incubation cells were fixed and analyzed for
apoptosis or cell proliferation assay respectively. (A) TUNEL assay
showed Dmp12/2 apoptotic cells in normal media are significantly
lower than WT. Also increasing the phosphate level significantly
increases the apoptosis level in Dmp12/2 cells compared to normal
media. While increased phosphate level does not have any
significant effect on WT cells apoptosis rate. (*P,0.05 compared
to WT in normal media, 1P,0.05 compared to Dmp12/2 in
normal media). (B) Cell proliferation assay does not show any
significant difference between Dmp12/2 cell proliferative activity
by increasing phosphate level, confirming the protective role of
DMP1 for osteoblasts in hyperphosphatemic environment.
Increased phosphate level is toxic to the cells if they do not
express DMP1, and increases apoptosis.
(TIF)
Figure S2 An increase of cell death in the compound
deficient bone. (A) There is a dramatic increase of apoptotic
cells in double deficient mice (Dmp12/2 kl/kl) compared to the
single kl/kl osteocytes and osteoblasts in the cortical bone of femur
(6 weeks old). (B) Hematoxylin and Eosin stain of femur cortical
bone of 6 weeks old animals shows numerous empty lacunae,
which represent dead osteocytes, in Dmp12/2kl/kl. (C) Quantita-
tive data suggest that the high empty lacunae rate in Dmp12/2kl/kl
group is significant compared to other groups (P,0.001, n= 4).
Both pieces of evidence support a protective role of DMP1 in
hyperphosphatemic environment.
(TIF)
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Figure S3 The Dmp1 lacZ knock-in transgene is ex-
pressed in blood vessels. Whole mount X-gal stain of a
heterozygous Dmp1-lacZ knock-in uterus overnight shows blue
stain blood vessel (6-mo old, left panel). A frozen section of this
whole mount X-gal stained tissue was count stained with Eosin,
displaying the blue stained cells in the blood vessel wall in small
arteries, small veins and arterioles.
(TIF)
Figure S4 The Dmp1 lacZ knock-in transgene is ex-
pressed in Kidney.Whole mount X-gal stain of a heterozygous
Dmp1-lacZ knock-in kidney overnight shows blue stain blood
vessel (6-mo old). A frozen section of this whole mount X-gal
stained kidney tissue was count stained with Eosin, displaying the
blue stained cells in the kidney renal tubules (insert).
(TIF)
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